John Theurer Cancer Center ( Site 0002)

Hackensack, New Jersey 07601

0 studies enrolling now · 1 studies all time

What they study most

Advanced/Metastatic Solid Tumors

Studies at this site

• Study of Selumetinib (MK-5618) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (MK-5618-001) — Stopped early